Search - tctmd.com

Displaying 621 - 640 of 709

Sort: Relevancy | Date

News Daily News

Observational Study Hints at Real Benefits for Patients Who Take PUFAs After Acute MI

November 30, 2015

News Daily News

Un Estudio Observacional Revela los Beneficios Reales de Pacientes a Tratamiento con AGPI Post-IAM

November 30, 2015

News Opinion Editor's Corner

My Takeaways From AHA 2015

Shelley Wood

November 18, 2015

News Conference News AHA 2015

PROMISE Analyses: Coronary CTA May Hold Some Benefits for Patients With Suspected CAD

Todd Neale

November 10, 2015

News Conference News AHA 2015

Knowing Genetic Risk for MI Motivates Patients, Physicians to Get Cholesterol Levels Lower

Yael L. Maxwell

November 08, 2015

News Conference News AHA 2015

AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More

Shelley Wood

November 05, 2015

News Daily News

La Puerta se Cierra para las Dietas Bajas en Grasas en lo que al Manejo del Peso a Largo Plazo se refiere

Todd Neale

November 01, 2015

News Daily News

Door Closing on Low-fat Diets for Long-term Weight Management

Todd Neale

November 01, 2015

Presentation

Effect of Low-fat vs Other Diet Interventions on Long-term Weight Change in Adults

Presenter: Deirdre Tobias

October 30, 2015

News Industry News

FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa

October 20, 2015

News Conference News TCT 2015

Keynote: Simplified Trials, Community Engagement Key to Reinvention of Clinical Research

October 13, 2015

News Industry News

Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union

September 28, 2015

News Daily News

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

September 22, 2015

News Daily News

RenalGuard Evita la LRA en Pacientes TAVR Mejor que una Solución Salina Estándar

September 22, 2015

News Industry News

Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha™ (Evolocumab)

September 11, 2015

News Industry News

FDA approves Repatha to treat certain patients with high cholesterol

August 28, 2015

News Industry News

New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN® (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial of JANUVIA® Will Be Presented at the European Society of Cardiology

August 20, 2015

News Industry News

Jardiance® demonstrated cardiovascular (CV) risk reduction in people with type 2 diabetes at high risk for CV events

August 20, 2015

News Industry News

Doctor's Best Introduces Two New Heart Health Supplements

August 11, 2015

News Industry News

Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia

July 24, 2015

Advertisement

Observational Study Hints at Real Benefits for Patients Who Take PUFAs After Acute MI

Un Estudio Observacional Revela los Beneficios Reales de Pacientes a Tratamiento con AGPI Post-IAM

My Takeaways From AHA 2015

PROMISE Analyses: Coronary CTA May Hold Some Benefits for Patients With Suspected CAD

Knowing Genetic Risk for MI Motivates Patients, Physicians to Get Cholesterol Levels Lower

AHA 2015 Promises Appropriate PCI, Ticagrelor Tolerance, Outcomes With IVUS, and More

La Puerta se Cierra para las Dietas Bajas en Grasas en lo que al Manejo del Peso a Largo Plazo se refiere

Door Closing on Low-fat Diets for Long-term Weight Management

Effect of Low-fat vs Other Diet Interventions on Long-term Weight Change in Adults

FDA approves Praxbind, the first reversal agent for the anticoagulant Pradaxa

Keynote: Simplified Trials, Community Engagement Key to Reinvention of Clinical Research

Regeneron and Sanofi Announce Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia in the European Union

RenalGuard Protects TAVR Patients Against AKI Better Than Does Standard Saline

RenalGuard Evita la LRA en Pacientes TAVR Mejor que una Solución Salina Estándar

Amgen Submits Application To FDA For New Delivery Option For Monthly Administration Of Repatha™ (Evolocumab)

FDA approves Repatha to treat certain patients with high cholesterol

New Analyses from the IMPROVE-IT Outcomes Study of VYTORIN® (ezetimibe and simvastatin) and the TECOS Cardiovascular Safety Trial of JANUVIA® Will Be Presented at the European Society of Cardiology

Jardiance® demonstrated cardiovascular (CV) risk reduction in people with type 2 diabetes at high risk for CV events

Doctor's Best Introduces Two New Heart Health Supplements

Regeneron and Sanofi Announce CHMP Recommends European Approval of Praluent® (alirocumab) for the Treatment of Hypercholesterolemia

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content